Hans-Based Cell of Origin Is Not of Prognostic Significance in Diffuse Large B-Cell Lymphoma Patients: A Retrospective Single-Center Study Conducted in 326 RCHOP-Treated Patients
COO according to Hans index is not a significant prognostic factor for DLBCL patients, but b2-microglobulin ≥3.5 mg/L and IPI 2-5 in both GC and non-GC patients can predict individually a higher risk for progression.
Authors
- Panagiotis Tsikouras (ORCID: https://orcid.org/0000-0002-9495-4424)
- Ιoannis Kotsianidis (ORCID: https://orcid.org/0000-0001-7668-0186)
- Menelaos Papoutselis (ORCID: https://orcid.org/0000-0002-1686-4992)
- Belkis Malkots
- Iliana Stamatiou (ORCID: https://orcid.org/0009-0007-6458-8201)
- Christoforos Roumpakis
- Konstantinos Zagoridis
- Panagiotis Skendros (ORCID: https://orcid.org/0000-0003-0456-7015)
- Konstantinos Liapis (ORCID: https://orcid.org/0000-0003-1165-9639)
- Georgios Kanelis
- Marianthi Symeonidou
- Zoe Bezirgiannidou (ORCID: https://orcid.org/0000-0002-8443-920X)
- Georgios Vrachiolias
- Stergios Intzes
- Lazaros Karatisidis
- Theodoros Mprotsis (ORCID: https://orcid.org/0000-0003-4713-4244)
- Emmanouil Spanoudakis
Institutions
- University of Thessaly (GR)
- Democritus University of Thrace (GR)
- Evangelismos Hospital (GR)
Publication Details
- Journal
- Acta Haematologica
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1159/000549608
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00